Novel Coronavirus (SARS-CoV-2/COVID-19)
AHA voices support for the National Coronavirus Commission Act (S. 412), legislation that would create a national commission to examine lessons learned from the COVID-19 pandemic and how to improve public health readiness.
The Food and Drug Administration granted an emergency use authorization for Johnson & Johnson’s single-dose COVID-19 vaccine.
The House of Representatives voted 219-212 to approve a modified version of the American Rescue Plan Act of 2021, legislation to provide reconciliation protection for a roughly $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and health systems.
The Centers for Medicare & Medicaid Services released guidance clarifying federal requirements for health plans to cover certain items and services related to diagnostic testing for COVID-19 without cost-sharing, prior authorization or other medical management requirements.
A summary of important information for providers on Johnson & Johnson’s COVID-19 vaccine.
The House of Representatives early this morning voted 219-212 to approve a modified version of the American Rescue Plan Act of 2021, legislation to provide reconciliation protection for a roughly $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and…
- Novel Coronavirus (SARS-CoV-2/COVID-19)
- Legislation and Legislative Advocacy
- Advocacy & Public Policy
- COVID-19: Vaccines and Therapeutics
- Medicaid
- Marketplace Issues/Stability
- Medicare DSH
- Substance Use Disorder
- Behavioral Health Intervention & Issues Prevention
- Workforce
- Skilled Nursing Facility PPS
- OSHA
- Rural issues
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee recommended the approval of Johnson & Johnson’s COVID-19 vaccine candidate.
The Substance Abuse and Mental Health Services Administration will host a March 3 roundtable discussion on the academic, social and emotional impacts of distance learning on children during the COVID-19 pandemic.
Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the second dose of the Pfizer vaccine, according to a study released by the Centers for Disease Control and Prevention.
AHA released a one-stop web hub for hospitals and health systems to find communication resources related to COVID-19 vaccines.